Company Filing History:
2 out of 86 
1 out of 1,179 
Years Active: 2016-2024
Title: Inventor Spotlight: Jennifer Terew
Introduction: Jennifer Terew is a prominent inventor based in Concord, MA, who has made significant contributions to the field of genetic therapies. With a total of three patents to her name, Terew is recognized for her innovative approaches to treating lysosomal storage diseases.
Latest Patents: Terew's latest patents focus on the "Methods and compositions for CNS delivery of heparan N-sulfatase." These inventions provide compositions and methods that enable the central nervous system (CNS) delivery of lysosomal enzymes, aiming for effective treatment options for lysosomal storage diseases. Specifically, her inventions include stable formulations for direct CNS intrathecal administration, which consist of heparan N-sulfatase protein, salt, and a polysorbate surfactant, targeting the treatment of Sanfilippo Syndrome Type A.
Career Highlights: Throughout her career, Jennifer Terew has worked with notable organizations such as Shire Human Genetic Therapies, Inc. and Takeda Pharmaceutical Company Limited. Her efforts in these companies have facilitated advancements in genetic therapeutics, leading to her innovative inventions being recognized in the field.
Collaborations: Terew's work has also been enriched by her collaborations with esteemed colleagues, including Farah Natoli and Gaozhong Zhu. Their combined expertise has contributed to the development and refinement of her inventions, furthering their impact in the area of CNS treatment.
Conclusion: Jennifer Terew exemplifies the spirit of innovation within the field of genetic therapies. With her focus on advancing treatments for rare lysosomal storage diseases, her contributions continue to pave the way for new therapeutic options and improved patient outcomes. Her patents not only highlight her ingenuity but also underscore the importance of collaboration in scientific advancements.